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Scott Earley, Thomas J. Heppner, Mark T. Nelson, Joseph E. Brayden Abstract-Vasodilatory factors produced by the endothelium are critical for the maintenance of normal blood pressure and flow. We hypothesized that endothelial signals are transduced to underlying vascular smooth muscle by vanilloid transient receptor potential (TRPV) channels. TRPV4 message was detected in RNA from cerebral artery smooth muscle cells. In patch-clamp experiments using freshly isolated cerebral myocytes, outwardly rectifying whole-cell currents with properties consistent with those of expressed TRPV4 channels were evoked by the TRPV4 agonist 4␣-phorbol 12,13-didecanoate (4␣-PDD) (5 mol/L) and the endothelium-derived arachidonic acid metabolite 11,12 epoxyeicosatrienoic acid (11, 12 EET) (300 nmol/L). Using high-speed laser-scanning confocal microscopy, we found that 11, 12 EET increased the frequency of unitary Ca 2ϩ release events (Ca 2ϩ sparks) via ryanodine receptors located on the sarcoplasmic reticulum of cerebral artery smooth muscle cells. EET-induced Ca 2ϩ sparks activated nearby sarcolemmal large-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channels, measured as an increase in the frequency of transient K ϩ currents (referred to as "spontaneous transient outward currents" [STOCs] ). 11,12 EET-induced increases in Ca 2ϩ spark and STOC frequency were inhibited by lowering external Ca 2ϩ from 2 mmol/L to 10 mol/L but not by voltage-dependent Ca 2ϩ channel inhibitors, suggesting that these responses require extracellular Ca 2ϩ influx via channels other than voltage-dependent Ca 2ϩ channels. Antisense-mediated suppression of TRPV4 expression in intact cerebral arteries prevented 11,12 EET-induced smooth muscle hyperpolarization and vasodilation. Thus, we conclude that TRPV4 forms a novel Ca 2ϩ signaling complex with ryanodine receptors and BK Ca channels that elicits smooth muscle hyperpolarization and arterial dilation via Ca 2ϩ -induced Ca 2ϩ release in response to an endothelial-derived factor. (Circ Res.
2005;97:1270-1279.)
Key Words: Ca 2ϩ sparks Ⅲ Ca 2ϩ transients Ⅲ eicosanoids Ⅲ ion channels Ⅲ ryanodine receptor Ⅲ vascular smooth muscle Ⅲ vasodilation D iffusible factors produced by the vascular endothelium are vital for the regulation of smooth muscle membrane potential, arterial tone, blood pressure, and blood flow. Epoxyeicosatrienoic acids (EETs), the cytochrome P450 epoxygenase products of arachidonic acid, 1 cause vasodilation and account for endothelium-derived hyperpolarizing factor (EDHF) activity in some vascular beds. 2, 3 Critical components of signaling pathways activated by these compounds are not fully understood. 1 Although evidence supportive of a receptor-dependent smooth muscle hyperpolarization mechanism has been presented, 4 the molecular identity of the "EET receptor" has not been reported. Vanilloid transient receptor potential (TRPV) channels are important sensors of biochemical and physiological stimuli. 5 Therefore, we tested the hypothesis that TRPV channels are involved in transducing endothelial signals to underlying vascular smooth muscle. EETs promote Ca 2ϩ influx in HEK cells overexpressing TRPV4 6 and increase intracellular [Ca 2ϩ ] in cultured smooth muscle cells. 7 In addition, activation of TRPV4 with the phorbol compound 4␣-phorbol 12,13-didecanoate 8 (4␣-PDD) increases intracellular [Ca 2ϩ ] in airway smooth muscle. 9 An elevation in intracellular [Ca 2ϩ ] is usually associated with vasoconstriction. Thus, these reports pose a paradox: How does EET-induced Ca 2ϩ influx cause vasodilation? A number of studies suggest involvement of large-conductance Ca 2ϩ -activated K ϩ (BK Ca ) channels in EET-induced smooth muscle hyperpolarization and vasodilation. 1 
Materials and Methods
Cerebral and cerebellar arteries used for these studies were isolated from male Sprague-Dawley rats (250 to 350 g; Charles River Laboratories, St Constant, Quebec, Canada). All animal use procedures were in accordance with institutional guidelines and approved by the Institutional Animal Care and Use Committee of the University of Vermont. Total RNA was extracted from whole brain, isolated cerebral arteries, and freshly dispersed cerebral artery smooth muscle cells, and RT-PCR was used to determine whether TRPV4 mRNA was present in these tissues. Forward and reverse primers specific for TRPV4 were TRPV4F (5Ј-GGGCAGCTCCCCAAAGTAGAA-3Ј) and TRPV4R (5Ј-GTGCCTGGGCCCAAGAAA-3Ј). These primers yield a 578-bp PCR product.
Whole-cell patch-clamp experiments were used to determine whether ion channels with biophysical properties similar to TRPV4 were present in freshly isolated cerebral artery myocytes. Currents were recorded during voltage ramps between Ϫ120 and ϩ80 mV before and after administration of 4␣-PDD or 11,12 EET and were normalized to membrane capacitance (pA/pF). Isolated smooth muscle cells were loaded with the rapid Ca 2ϩ indicator dye fluo-4 (Molecular Probes), and the effects of 11,12 EET on Ca 2ϩ spark frequency were evaluated using high-speed (30 to 60 frames/s) laser-scanning confocal microscopy. 15, 16 Cerebral myocytes were also patch clamped in the perforated-patch configuration to examine the effects of 11,12 EET on the frequency of transient macroscopic BK Ca currents ("spontaneous transient outward currents" [STOCs] ).
Downregulation of TRPV4 expression in isolated cerebral arteries was accomplished with antisense oligonucleotides. The sequence of the TRPV4 antisense oligonucleotide used for these studies was 5Ј-CATCACCAGGATCTGCCATACTG-3Ј 17 (Operon Biotechnologies Inc). The complementary sequence was used as the sense (control) oligonucleotide. Sense and antisense oligonucleotides were introduced into intact cerebral arteries using a reversible permeabilization procedure. 18 Following reversal of permeabilization, arteries were organ cultured for 2 to 3 days in DMEM/F-12 medium without serum to allow for TRPV4 downregulation. Semiquantitative RT-PCR was used to evaluate the effects of antisense treatment on TRPV4 mRNA levels. Smooth muscle cells isolated from cultured arteries were patch clamped in whole-cell or perforated-patch con- 
Results
TRPV4-Like Channels Are Present in Cerebral Artery Smooth Muscle
Message encoding TRPV4 was found in rat brain, cerebral arteries, and isolated cerebral artery smooth muscle cells (Figure 1a, inset) . PCR products were not detected when template cDNA was omitted from the PCR (Figure 1a) or when reverse-transcription reactions were performed in the absence of reverse transcriptase (not shown). Because a number of transient receptor potential channels, including TRPC1, 19 TRPC3, 19 -21 TRPC4, 19 TRPC6, 19, 21 and TRPM4, 22 are also present in cerebral artery myocytes, conventional whole-cell patch-clamp experiments were performed to determine whether ion channels with biophysical properties similar to those of cloned TRPV4 channels were present in these cells. The TRPV4 agonist 4␣-PDD (5 mol/L) activated an outwardly rectifying current in these cells (Figure 1a and 1b). 11,12 EET (300 nmol/L) also rapidly (Յ1 minute) evoked a current with similar current-voltage characteristics ( Figure 1c ). Activation of whole-cell currents by 11,12 EET (300 nmol/L) was blocked by prior administration of the TRPV channel inhibitor ruthenium red (RR) (1 mol/L) (Figure 1d and 1e). The rapid activation and inactivation of 11,12 EET-evoked currents in cerebral myocytes ( Figure 1f ) was similar to the reported time course of EET-induced Ca 2ϩ influx and whole-cell currents in cultured cells overexpressing TRPV4. 6 Activation of inward, but not outward, currents by 11,12 EET (300 nmol/L) was absent when N-methyl-Dglucamine (NMDG) was substituted for cations in the extracellular solution (Figure 1g and 1h) . Thus, properties of this current in cerebral myocytes, such as current-voltage relationships, activation by 4␣-PDD and 11,12 EET, and block by RR, are consistent with previously described characteristics of cloned TRPV4 channels 6, 8, 23 and, combined with expression of TRPV4 mRNA in these cells, strongly suggests that functional TRPV4 channels are present in cerebral artery smooth muscle.
EETs Increase Ca 2؉ Spark and Transient BK Ca Activity in Cerebral Myocytes
EETs, which activate TRPV4 channels, 6 have also been shown to induce membrane potential hyperpolarization and relaxation of arteries, which is prevented by blocking BK Ca channels. 2 We, therefore, examined the effects of EETs on intracellular Ca 2ϩ dynamics in cerebral artery smooth muscle cells loaded with the rapid Ca 2ϩ indicator dye fluo-4. 11,12 EET (300 nmol/L) increased Ca 2ϩ spark frequency nearly 2-fold in freshly isolated cerebral myocytes (Figure 2a and  2b ). Previous reports demonstrate that Ca 2ϩ sparks stimulate nearby sarcolemmal BK Ca channels to cause transient K ϩ currents (STOCs). 10 specific BK Ca channel blocker iberiotoxin (100 nmol/L; 0.33Ϯ0.11 versus 0.05Ϯ0.02 Hz; nϭ3). In addition, 11,12 EET (300 nmol/L) did not increase the open probability (NP o ) of BK Ca channels in membrane patches obtained from cerebral artery myocytes (online Figure I) . These findings strongly support the concept that EETs signal RyRs to increase Ca 2ϩ sparks, which in turn activate BK Ca channels. ] was maintained at physiological levels (2 mmol/L) ( Figure 3a) . In contrast, when extracellular [Ca 2ϩ ] was reduced to 10 mol/L in the presence of diltiazem, Ca 2ϩ spark frequency did not differ between control and 11,12 EETtreated cells (Figure 3a) . 11,12 EET (300 nmol/L) also increased STOC frequency when external [Ca 2ϩ ] was 2 mmol/L and VDCCs were blocked (1 mol/L nisoldipine), whereas when bath [Ca 2ϩ ] was reduced to 10 mol/L while VDCC inhibition was maintained, STOC activity was not altered by 11,12 EET administration (Figure 3b and 3c ). These findings demonstrate that EET-induced increases in Ca 2ϩ spark and STOC frequency are dependent on Ca 2ϩ entry via a non-VDCC channel.
EET-Induced Increases in
EET-Induced Increases in Transient BK Ca Activity Are TRPV4 Dependent TRPV4 channels are activated by EETs, 6 consistent with the possibility that these channels could mediate EET-induced hyperpolarization in cerebral artery smooth muscle cells. The TRPV antagonist RR (1 mol/L), applied externally, blocked 11,12 EET-induced (300 nmol/L) increases in STOC frequency without altering basal STOC activity (Figure 4a and  4b ). In addition, RR (1 mol/L) reversed 11,12 EET-induced increases in STOC frequency to control levels (Figure 4c and  4d) . The TRPV4 agonist 4␣-PDD (5 mol/L) also elevated STOC frequency in cerebral myocytes, and this response was inhibited by RR (1 mol/L) (Figure 4e and 4f) .
To examine further the relationship between EET-induced, TRPV4-mediated Ca 2ϩ influx and smooth muscle hyperpo- 
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larization, TRPV4 expression was suppressed in intact vessels using antisense oligonucleotides. Cerebral arteries were permeabilized, 18 were exposed to TRPV4 sense or antisense oligonucleotides and, following reversal of permeabilization, were organ cultured for 2 to 3 days to allow TRPV4 downregulation. 21, 22 Semiquantitative RT-PCR was used to examine the efficacy of these procedures, and TRPV4 mRNA levels were found to be diminished in antisense-versus sense-treated arteries (Figure 5a, inset) . 11,12 EET (300 nmol/L) activated an outwardly rectifying current in smooth muscle cells from sense-treated vessels that had a similar current-voltage relationship, current density, (Figure 6a and 6b) , whereas Ca 2ϩ spark frequency in antisense-treated vessels was not altered by 11,12 EET administration (Figure 6a and 6b) . Consistent with these observations, 11,12 EET (300 nmol/L) elevated STOC frequency in cerebral myocytes isolated from sense-treated, Figure 5 . TRPV4 downregulation attenuates 11,12 EET-activated whole-cell currents. a, Whole-cell currents activated by 11,12 EET (300 nmol/L) in smooth muscle cells isolated from TRPV4 sense-treated cerebral arteries. Inset, Semiquantitative RT-PCR demonstrating the effects of antisense treatment on TRPV4 expression in cerebral arteries. AS indicates antisense; NT, no template control. b, Whole-cell currents activated by 11,12 EET (300 nmol/L) in smooth muscle cells isolated from TRPV4 antisense-treated cerebral arteries. c, Difference currents before and after 11,12 EET administration for smooth muscle cells from TRPV4 sense and antisense-treated arteries. d, Summary data showing the effect of TRPV4 downregulation on 11,12 EET-induced (difference) currents at Ϫ80 and ϩ80 mV. *PϽ0.05 vs sense-treated arteries (Ϫ80 mV), # PϽ0.05 vs sense-treated arteries (ϩ80 mV). nϭ5 for both groups. e, Time course of 11,12 EET-induced current activation in TRPV4 sense-and antisense-treated arteries.
Earley et al TRPV4 Mediates Smooth Muscle Hyperpolarization
but not antisense-treated, arteries (Figure 6c and 6d ). These findings demonstrate that TRPV4 is a critical mediator of 11,12 EET-induced increases in Ca 2ϩ spark-activated transient BK Ca currents in cerebral artery smooth muscle.
TRPV4 Mediates EET-Induced Smooth Muscle Hyperpolarization and Vasodilation
An elevation of Ca 2ϩ spark frequency can dilate cerebral arteries through activation of BK Ca channels. Therefore, the relationships between TRPV4 downregulation, EET-induced changes in Ca 2ϩ spark frequency, and alterations in smooth muscle membrane potential and vasomotor responses were examined. 11,12 EET (300 nmol/L) caused an approximately 10 mV smooth muscle membrane potential hyperpolarization in pressurized (60 mm Hg), TRPV4 sense-treated arteries (Figure 7a and 7b) . In contrast, membrane potential of cerebral myocytes in antisense-treated vessels was not significantly altered by 11,12 EET (Figure 7a and 7b) . TRPV4 sense-and antisense-treated vessels constricted to the same extent in response to a depolarizing concentration of KCl (60 mmol/L) or pressure (60 mm Hg), suggesting that membrane depolarization-induced Ca 2ϩ influx through VDCCs was unaffected. Vasodilation in response to the K ATP channel agonist pinacidil (10 mol/L) also did not differ between groups (sense, 83.3Ϯ3.7% of passive diameter; antisense, 86.7Ϯ5.5%; nϭ3 for each group). In contrast, 11,12 EETinduced vasodilator responses were significantly inhibited by TRPV4 downregulation (Figure 7c and 7d) , whereas TRPV4 sense-treated arteries dilated to an extent similar to that of freshly isolated arteries (Figure 7c and 7d) . In the presence of ryanodine (10 mol/L), freshly isolated cerebral arteries exhibited only slight, statistically insignificant dilation (6.9Ϯ2.5 m; nϭ3) in response to 11,12 EET (300 nmol/L), providing further evidence for a Ca 2ϩ spark-dependent mechanism in this response. These findings demonstrate a role for TRPV4 and RyRs in EET-induced smooth muscle hyperpolarization and vasodilation.
Discussion
The major findings of this study are as follows: (1) (4) antisense-mediated TRPV4 downregulation in isolated cerebral arteries blocks EET-induced increases in Ca 2ϩ spark and transient BK Ca channel activity as well as membrane potential hyperpolarization and vasodilation. Thus, our findings show that in cerebral artery myocytes, Ca 2ϩ influx through TRPV4, stimulated by 11,12 EET, 6 increases Ca 2ϩ spark frequency and BK Ca channel activity, resulting in cerebral myocyte hyperpolarization. Consistent with an important functional role for this pathway, suppression of TRPV4 expression in intact cerebral arteries prevents 11,12 EET-induced smooth muscle hyperpolarization and vasodilation.
Cytochrome P450 epoxygenase products are recognized as potent vasodilatory factors produced by the vascular endothelium. 3, 24 Elucidation of the intracellular signaling pathways responsible for smooth muscle cell hyperpolarization by these compounds has been the subject of considerable effort. An important role for K ϩ channel activation in hyperpolarizing and vasodilatory response has been demonstrated in a number of previous reports. Although evidence suggesting activation of K ATP channels by EETs has been presented, 25 most studies support a role for BK Ca channels in EET-induced hyperpolarization. The simplest explanation for the role of this channel in vascular responses is direct activation of BK Ca by EETs. Although data supporting this mechanism have been reported, 26 our findings (online Figure I) are in agreement with a number of previous reports 4, 27, 28 and demonstrate no direct effect of 11,12 EET on BK Ca NP o in isolated membrane patches. These data suggest that, rather than acting directly on the channel, EETs activate intracellular signaling pathways that ultimately cause smooth muscle hyperpolarization via BK Ca channels. Recently reported findings that TRPV4-dependent currents are activated by EETs 6 prompted our investigation of a potential role for this channel in vascular control.
We show here that stimulation of Ca 2ϩ influx via TRPV4 by an endothelium-derived factor (11,12 EET) can alter local Ca 2ϩ signaling, generating membrane potential hyperpolarization and vasodilation. This is the first reported example of Ca 2ϩ influx-induced smooth muscle cell membrane hyperpolarization. We propose that, similar to CICR 13, 14 mechanisms that amplify Ca 2ϩ influx through VDCC to cause cardiac myocyte contraction, 29 TRPV4-dependent Ca 2ϩ signals are amplified by opening SR RyRs 11 and serve to increase Ca 2ϩ spark frequency. TRPV4-dependent Ca 2ϩ influx could potentially increase SR Ca 2ϩ loading, which would also result in elevated Ca 2ϩ spark activity. 12 However, 11,12 EET did not increase Ca 2ϩ spark amplitude, arguing against increased SR Ca 2ϩ loading. 11,12 EET could also activate Ca 2ϩ spark activity by acting directly on RyRs. However, it is unlikely that TRPV4 downregulation would influence this response. We propose that TRPV4-dependent Ca 2ϩ signals ultimately result in smooth muscle hyperpolarization and vasodilation through activation of Ca 2ϩ sparks and BK Ca -dependent transient membrane hyperpolarization (Figure 8 ). The hypothesized signaling pathway predicts close coupling between TRPV4 channels and the SR to allow local TRPV4-mediated Ca 2ϩ influx to stimulate nearby RyRs. Although direct activation of BK Ca channels by TRPV4-dependent Ca 2ϩ influx is possible, BK Ca activation by this mechanism would be sustained, rather than transient in nature. For TRPV4-mediated Ca 2ϩ influx to directly cause increases in transient BK Ca activity (STOCs), TRPV4 channels would need to permit Ca 2ϩ entry that has the amplitude and time course of a Ca 2ϩ spark through a RyR. There is no evidence that TRPV4 channels operate in this manner; thus, our findings are consistent with TRPV4-dependent currents modulating RyR activity. Significantly, our findings address previously unresolved issues concerning EET-induced responses in the vasculature and suggest that TRPV4 may act as an extracellular receptor for 11,12 EET in arterial smooth muscle cells. Transient receptor potential channels are ubiquitously expressed, 5 and dynamic Ca 2ϩ release events influence the properties of a number of tissues, including sensory neurons, 30 pancreatic ␤ cells, 31 and cardiac myocytes, 29 as well as many types of smooth muscle. 32 Thus, in addition to providing novel information regarding regulation of vascular tone, our observations suggest the possibility that TRPV4 (and perhaps other TRPV channels) can alter the function of many types of excitable cells by modulating complex Ca 2ϩ events. Furthermore, as TRPV channels are activated by a number of stimuli, such as changes in osmolarity, 23 temperature (in the physiological range), 33 and fatty acids, 34 this mechanism may constitute a fundamental way in which environmental factors influence excitable cells through a local Ca 2ϩ signaling mechanism involving CICR.
1
EXPANDED MATERIALS and METHODS
Animals
Male Sprague-Dawley rats (300-400 g; Charles River Laboratories; St.
Constant, Quebec, Canada) were used for these studies. Animals were deeply anesthetized with pentobarbital sodium (50 mg. i.p.) and euthanized by exsanguination according to a protocol approved by the Institutional Animal 
Cerebral Artery Smooth Muscle Cell Preparation
To isolate VSM cells, vessels were cut into 2-mm segments, and placed in the following cell isolation solution (in mmol/L): 60 NaCl, 80 Na glutamate, 5 KCl, 2 MgCl 2 , 10 glucose, and 10 HEPES; pH 7.2. Arterial segments were initially incubated at 37°C in 0.3 mg/ml papain (Worthington) and 0.3 mg/ml dithioerythritol for 15 min, followed by 15 min incubation in 0.67 mg/ml type F collagenase (Sigma), 0.33 mg/ml type H collagenase (Sigma), and 100 µmol/L CaCl 2 . The digested segments were then washed three times in ice-cold isolation solution and triturated to release VSM cells. Cells were stored on ice in isolation solution for use the same day.
2
RNA Preparation and RT-PCR
RNA was prepared from whole rat brain, cerebral artery homogenates, and isolated smooth muscle cells. Smooth muscle cells (~1000) were visually identified under phase contrast microscopy (600X) and harvested using a micropipette directed by a micromanipulator. Following total RNA extraction (RNeasy mini kit; Qiagen Inc.), first strand cDNA was synthesized using the superscript reverse transcriptase (RT) kit (Qiagen Inc). 5 µl of each first strand cDNA reaction was subsequently placed in a PCR reaction solution (50 µl) containing forward and reverse primers, dNTPs, 2 x reaction buffer "J" 
Ca
2+ Imaging
Ca 2+ sparks were recorded according to previously described methods STOCs were defined as transient current events that were greater than three times the expected unitary current for BK Ca channels at the membrane potential for which the recordings were obtained. For a membrane potential of 0 mV, the threshold current was set at 24 pA. All events greater than the threshold current were counted and STOC frequency was calculated by dividing the number of events by the duration of the recording. All recordings were at least 1 minute in duration. All patch clamp experiments were performed at room temperature (~22ºC).
5
TRPV4 Antisense Procedures
The sequence of the antisense oligonucleotide used for these studies (previously shown to suppress TRPV4 expression 2 ) was 5'-CATCACCAGGATCTGCCATACTG-3'. The last three bases on the 5' and 3' ends of the oligonucleotide were phosphorothioated to limit degradation by cellular nucleases. Oligonucleotides were dissolved at a concentration of 2 mM in nuclease-free water and were introduced into intact cerebral arteries using a reversible permeabilization procedure as previously described 3, 4 . 
Isolated Vessel Experiments
Isolated vessel procedures were performed essentially as previously EET (300 nM). n = 5-7 at each membrane potential. There were no significant differences.
